Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer

EMSY, a BRCA2–associated protein, is amplified and overexpressed in various sporadic cancers. This is the first study assessing the clinical impact of its expression and polymorphisms on ovarian cancer (OvCa) outcome in the context of the chemotherapy regimen used. In 134 frozen OvCa samples, we ass...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Dansonka-Mieszkowska, Agnieszka, Szafron, Lukasz M., Moes-Sosnowska, Joanna, Kulinczak, Mariusz, Balcerak, Anna, Konopka, Bozena, Kulesza, Magdalena, Budzilowska, Agnieszka, Lukasik, Martyna, Piekarska, Urszula, Rzepecka, Iwona K., Parada, Joanna, Zub, Renata, Pienkowska-Grela, Barbara, Madry, Radoslaw, Siwicki, Jan K., Kupryjanczyk, Jolanta
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915152/
https://ncbi.nlm.nih.gov/pubmed/29707144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24878
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados